Genentech parent's Parkinson's drug trial fails with Bay Area partner
April 22, 2020 at 17:25 PM EDT
The second part of the study is ongoing but has been slowed by the COVID-19 pandemic.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|